Monday, March 21, 2016

UPDATE 2-BioMarin drug fails to show inattention, mood benefit in study

March 21 (Reuters) - BioMarin Pharmaceutical Inc's

drug met the main goal of reducing a toxic buildup of an amino

acid in the blood of patients with a genetic disorder, but did

not show benefit in...

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)